Dr. Linxian Li obtained his PhD degree at Ruprecht-Karls-University of Heidelberg in Germany and completed a postdoctoral research with Prof. Robert S. Langer at Massachusetts Institute of Technology. He is currently an assistant professor at Karolinska Institutet. Committed to translate new materials for medical use, he focuses on developing biomaterials to deliver RNA therapeutics and engineering synthetic surfaces for cell therapy. His work has resulted in over 20 publications including papers, patents and patent applications. These patents have been licensed to chemical and biotechnology companies, and several products that have been commercialized.